Search | JOV | ARVO Journals

Showing 1 – 20 of 31

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

An Embryo-Fetal Development Study of Tarcocimab after Intravenous Injection in Rabbits

John Sinclair; Janine Lu; Hong Liang; Elise Lewis; Rachel Babineau; Alan Hoberman; D. Victor Perlroth

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5100.

Glaucoma January 2022

Matrix Mechanotransduction via Yes-Associated Protein in Human Lamina Cribrosa Cells in Glaucoma

PDF

Rory Murphy; Mustapha Irnaten; Alan Hopkins; Jeffrey O'Callaghan; W. Daniel Stamer; Abbot F. Clark; Deborah Wallace; Colm J. O'Brien
TAGS: glaucoma, proteins, verteporfin, cribriform plate, mechanotransduction, cellular
Invest. Ophthalmol. Vis. Sci.. 2022; 63(1):16. https://doi.org/10.1167/iovs.63.1.16

ARVO Annual Meeting Abstract June 2021

Elucidating the role of inner blood retina barrier integrity in the development of dry AMD

Deirdre Harford; Natalie Hudson; Aisling Naylor; Jeffrey O'Callaghan; Alan Hopkins; Sarah Doyle; Matthew Campbell; Mark Cahill

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):293.

ARVO Annual Meeting Abstract June 2020

Inner blood retinal barrier (iBRB) integrity exhibits circadian medicated cycling in human subjects

Aisling Naylor; Natalie Hudson; Alan Hopkins; Sarah Doyle; Mark Cahill; Matthew Campbell

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2643.

ARVO Annual Meeting Abstract July 2019

The Role of Yes-Associated Protein (YAP) in Mechanotransduction at the Lamina Cribrosa and its Potential as a Novel Therapeutic Target In Glaucoma.

Rory Murphy; Alan Hopkins; Mustapha Irnaten; W Daniel Stamer; Abbot F Clark; Deirdre Brennan; Deborah Wallace; Colm J O'Brien

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1786.

ARVO Annual Meeting Abstract July 2019

Fundus fluorescein angiography (FFA) in human subjects displays circadian variation

Alan Hopkins; Natalie Hudson; Sarah Doyle; Mark Cahill; Matthew Campbell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5268.

ARVO Annual Meeting Abstract July 2019

The role of lamina cribrosa tissue stiffness as a fundamental biomechanical driver of pathological glaucomatous cupping

Colm J O'Brien; Rory Murphy; Mustapha Irnaten; Alan Hopkins

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6187.

Vision Sciences Society Annual Meeting Abstract August 2014

Apparent speed of a rotating disk varies with texture density

Stuart Anstis; Alan Ho

Journal of Vision. 2014; 14(10):1333. https://doi.org/10.1167/14.10.1333

Research Opportunities April 2014

Drug and Gene Delivery to the Back of the Eye: From Bench to Bedside

PDF

Cheryl L. Rowe-Rendleman; Shelley A. Durazo; Uday B. Kompella; Kay D. Rittenhouse; Adriana Di Polo; Alan L. Weiner; Hans E. Grossniklaus; Muna I. Naash; Alfred S. Lewin; Alan Horsager; Henry F. Edelhauser
TAGS: drug delivery systems, eye, genes, animal model, gene therapy, proteins, nanoparticles, hydrogels, retina, molecule
Invest. Ophthalmol. Vis. Sci.. 2014; 55(4):2714-2730. https://doi.org/10.1167/iovs.13-13707

Vision Sciences Society Annual Meeting Abstract July 2013

Adaptation to twinkle and flicker

Stuart Anstis; Alan Ho; Neal Dykmans

Journal of Vision. 2013; 13(9):298. https://doi.org/10.1167/13.9.298

Vision Sciences Society Annual Meeting Abstract July 2013

Re-pairing: Perceptual reorganization of moving visual patterns from sensory fusion.

Alan Ho; Stuart Anstis

Journal of Vision. 2013; 13(9):815. https://doi.org/10.1167/13.9.815

ARVO Annual Meeting Abstract June 2013

Macular pigment optical density response to supplemental macular carotenoids in subjects with and without age-related macular degeneration

Katherine Meagher; David Thurnham; Stephen Beatty; Alan Howard; Eithne Connolly; John Nolan; Macular Pigment Research Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3771.

ARVO Annual Meeting Abstract June 2013

An Investigation into Declared vs Actual Content of Commercially Available Food Supplements Containing the Macular Carotenoids

Sakina Kashani; Katherine Meagher; Stephen Beatty; David Thurnham; Alan Howard; John Nolan

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3772.

ARVO Annual Meeting Abstract June 2013

The relationship between visual performance and AMD severity in subjects with early age-related macular degeneration

John Nolan; Sarah Sabour-Pickett; Jim Stack; James Loughman; Alan Howard; Stephen Beatty; Macular Pigment Research Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3775.

Retina November 2012

The Impact of Macular Pigment Augmentation on Visual Performance Using Different Carotenoid Formulations

PDF

James Loughman; John M. Nolan; Alan N. Howard; Eithne Connolly; Katie Meagher; Stephen Beatty
TAGS: carotenoids, pigment, placebos, vision, contrast sensitivity
Invest. Ophthalmol. Vis. Sci.. 2012; 53(12):7871-7880. https://doi.org/10.1167/iovs.12-10690

ARVO Annual Meeting Abstract March 2012

Macular Pigment Response To Three Different Macular Carotenoid Interventions In Patients With Early Age-Related Macular Degeneration

John M. Nolan; Sarah Sabour-Pickett; Eithne Connolly; Loughman James; Alan Howard; Stephen Beatty

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3368.

ARVO Annual Meeting Abstract March 2012

Effect Of Carotenoid Supplementation On Macular Pigment Optical Density And Visual Performance In Normal Observers: The Most Vision Trial

James Loughman; Stephen Beatty; Alan Howard; Eithne Connolly; John M. Nolan

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3376.

ARVO Annual Meeting Abstract March 2012

Comparison Of Serum Response To Supplements Containing The Macular Carotenoids In Normals And In Patients With AMD

Katherine A. Meagher; John M. Nolan; David I. Thurnham; Wayne Cummins; Alan N. Howard; Stephen Beatty; James Loughman

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3366.

Translational Research January 2012

Frequency and Amplitude Modulation Have Different Effects on the Percepts Elicited by Retinal Stimulation

PDF

Devyani Nanduri; Ione Fine; Alan Horsager; Geoffrey M. Boynton; Mark S. Humayun; Robert J. Greenberg; James D. Weiland
TAGS: accommodation phosphene
Invest. Ophthalmol. Vis. Sci.. 2012; 53(1):205-214. https://doi.org/10.1167/iovs.11-8401

Clinical Trials November 2011

Supplementation with All Three Macular Carotenoids: Response, Stability, and Safety

PDF

Eithne E. Connolly; Stephen Beatty; James Loughman; Alan N. Howard; Michael S. Louw; John M. Nolan
TAGS: carotenoids, safety, lutein, pathology, clinical
Invest. Ophthalmol. Vis. Sci.. 2011; 52(12):9207-9217. https://doi.org/10.1167/iovs.11-8025

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

An Embryo-Fetal Development Study of Tarcocimab after Intravenous Injection in Rabbits

Matrix Mechanotransduction via Yes-Associated Protein in Human Lamina Cribrosa Cells in Glaucoma

Elucidating the role of inner blood retina barrier integrity in the development of dry AMD

Inner blood retinal barrier (iBRB) integrity exhibits circadian medicated cycling in human subjects

The Role of Yes-Associated Protein (YAP) in Mechanotransduction at the Lamina Cribrosa and its Potential as a Novel Therapeutic Target In Glaucoma.

Fundus fluorescein angiography (FFA) in human subjects displays circadian variation

The role of lamina cribrosa tissue stiffness as a fundamental biomechanical driver of pathological glaucomatous cupping

Apparent speed of a rotating disk varies with texture density

Drug and Gene Delivery to the Back of the Eye: From Bench to Bedside

Adaptation to twinkle and flicker

Re-pairing: Perceptual reorganization of moving visual patterns from sensory fusion.

Macular pigment optical density response to supplemental macular carotenoids in subjects with and without age-related macular degeneration

An Investigation into Declared vs Actual Content of Commercially Available Food Supplements Containing the Macular Carotenoids

The relationship between visual performance and AMD severity in subjects with early age-related macular degeneration

The Impact of Macular Pigment Augmentation on Visual Performance Using Different Carotenoid Formulations

Macular Pigment Response To Three Different Macular Carotenoid Interventions In Patients With Early Age-Related Macular Degeneration

Effect Of Carotenoid Supplementation On Macular Pigment Optical Density And Visual Performance In Normal Observers: The Most Vision Trial

Comparison Of Serum Response To Supplements Containing The Macular Carotenoids In Normals And In Patients With AMD

Frequency and Amplitude Modulation Have Different Effects on the Percepts Elicited by Retinal Stimulation

Supplementation with All Three Macular Carotenoids: Response, Stability, and Safety

To View More...

You must be signed into an individual account to use this feature.